This 2004 pilot study evaluated the impact of systemic ozone therapy on tumor oxygenation in 18 patients with advanced cancers. Administered via autohemotransfusion over one week, ozone therapy did not significantly alter overall tumor oxygenation levels. However, it notably reduced the proportion of severely hypoxic tumor regions (pO₂ ≤10 mmHg
